Harmony Biosciences Fair Value
HR
The fair market value of HRMY stock is 37.42 USD. Relative to the market price of 34.28 USD Harmony Biosciences is undervalued by 9.2%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Harmony Biosciences Valuation
Current HRMY share ticker price is 34.28 USD.
The fair value level of 37.42 USD can be considered as an effective entry point for long-term investors to start investing in HRMY stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 9% lower its fair value
Current price is 26% higher its minimum value
Current price is 419% lower its maximum value
Market price:
HRMY stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Harmony Biosciences Holdings Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
82.94
2
Median P/E over 5 years
17.45
3
Minimum P/E over 5 years
11.79
4
Earning per share (last 12 months)
2.14 USD
Maximum value
1
x
4
=
177.88 USD
Fair value
2
x
4
=
37.42 USD
Minimum value
3
x
4
=
25.29 USD
Harmony Biosciences Holdings Inc price metrics
-3.04
Annual return (geometric mean)
56.72
Risk (standard deviation) of returns
β
0.8
Beta (volatility compared to market)